Henan Genuine Biotech Co., Ltd.

This study tested how the drug azvudine moves through the body and whether it is safe in 24 healthy adults (ages 18-45) and healthy elderly people (ages 60-85). Participants took a single dose of 5 mg, then after a break took the same dose daily for 7 days. The goal was to measur…

This completed Phase 1 trial tested how the HIV drug azvudine (FNC) interacts with another HIV drug, Aluvia (lopinavir/ritonavir), in 15 healthy adults. Participants took the drugs alone and together over three 5-day cycles. The goal was to measure drug levels in the blood and ch…